Shirin Kalimuddin

12.4k total citations · 2 hit papers
63 papers, 3.5k citations indexed

About

Shirin Kalimuddin is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Shirin Kalimuddin has authored 63 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Infectious Diseases, 16 papers in Epidemiology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Shirin Kalimuddin's work include COVID-19 Clinical Research Studies (19 papers), Mosquito-borne diseases and control (14 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Shirin Kalimuddin is often cited by papers focused on COVID-19 Clinical Research Studies (19 papers), Mosquito-borne diseases and control (14 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Shirin Kalimuddin collaborates with scholars based in Singapore, United States and United Kingdom. Shirin Kalimuddin's co-authors include Jenny G. Low, Anthony T. Tan, Antonio Bertoletti, Eng Eong Ooi, Lin‐Fa Wang, C Tham, Wan Ni Chia, Nina Le Bert, Adeline Chia and Kamini Kunasegaran and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Shirin Kalimuddin

60 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

2020 1.2k citations Nina Le Bert, Anthony T. Tan et al. profile →
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients

2021 440 citations Anthony T. Tan, Martin Linster et al. Cell Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shirin Kalimuddin Singapore	21	2.5k	648	582	581	385	63	3.5k
Barnaby Edward Young Singapore	30	2.9k 1.2×	678 1.0×	771 1.3×	378 0.7×	602 1.6×	108	4.2k
Hye Won Jeong South Korea	28	1.7k 0.7×	311 0.5×	312 0.5×	363 0.6×	948 2.5×	107	2.8k
Αndreas Mentis Greece	32	818 0.3×	542 0.8×	157 0.3×	515 0.9×	592 1.5×	109	3.2k
Sook‐In Jung South Korea	30	1.8k 0.7×	334 0.5×	179 0.3×	163 0.3×	1.2k 3.2×	166	3.5k
Ali S. Omrani Saudi Arabia	22	1.8k 0.7×	170 0.3×	531 0.9×	105 0.2×	466 1.2×	79	2.6k
Satoshi Kutsuna Japan	23	1.9k 0.8×	330 0.5×	353 0.6×	138 0.2×	465 1.2×	191	3.1k
Ali Albarrak Saudi Arabia	28	3.7k 1.5×	219 0.3×	583 1.0×	177 0.3×	865 2.2×	52	4.5k
Fehmı Tabak Türkiye	31	1.2k 0.5×	362 0.6×	318 0.5×	268 0.5×	2.5k 6.4×	215	4.5k
Jiwon Jung South Korea	24	1.3k 0.5×	322 0.5×	194 0.3×	83 0.1×	771 2.0×	206	2.6k
Po‐Lin Chen Taiwan	29	771 0.3×	269 0.4×	127 0.2×	538 0.9×	465 1.2×	113	2.4k

Countries citing papers authored by Shirin Kalimuddin

Since Specialization

Citations

This map shows the geographic impact of Shirin Kalimuddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirin Kalimuddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirin Kalimuddin more than expected).

Fields of papers citing papers by Shirin Kalimuddin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shirin Kalimuddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirin Kalimuddin. The network helps show where Shirin Kalimuddin may publish in the future.

Co-authorship network of co-authors of Shirin Kalimuddin

This figure shows the co-authorship network connecting the top 25 collaborators of Shirin Kalimuddin. A scholar is included among the top collaborators of Shirin Kalimuddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shirin Kalimuddin. Shirin Kalimuddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kalimuddin, Shirin, Po Ying Chia, Jenny G. Low, & Eng Eong Ooi. (2025). Dengue and severe dengue. Clinical Microbiology Reviews. 38(4). e0024424–e0024424. 2 indexed citations

Ooi, Eng Eong & Shirin Kalimuddin. (2024). Lessons for dengue vaccines from a human challenge study. The Lancet Infectious Diseases. 24(8). 801–803. 1 indexed citations

Anderson, Danielle E., Abhay P. S. Rathore, Chinmay Kumar Mantri, et al.. (2023). Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19. Journal of Clinical Investigation. 133(19). 14 indexed citations

Chan, Kuan Rong, Dorothy Hui Lin Ng, Shijie Qin, et al.. (2023). Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis. EBioMedicine. 89. 104472–104472. 9 indexed citations

Tan, Yi Han, Yahua Chen, David Chien Lye, et al.. (2023). Acquisition of regulator on virulence plasmid of hypervirulent Klebsiella allows bacterial lifestyle switch in response to iron. mBio. 14(4). e0129723–e0129723. 19 indexed citations

Kalimuddin, Shirin, October M. Sessions, Kuan Rong Chan, et al.. (2023). An experimental medicine decipher of a minimum correlate of cellular immunity: Study protocol for a double-blind randomized controlled trial. Frontiers in Immunology. 14. 1135979–1135979. 3 indexed citations

Yoong, Joanne, James S. Molton, Ying Ding, et al.. (2023). Cost-minimization analysis of oral versus intravenous antibiotic treatment for Klebsiella pneumoniae liver abscess. Scientific Reports. 13(1). 9774–9774. 4 indexed citations

Ong, Eugenia Z., Jia Xin Yee, Justin S. G. Ooi, et al.. (2022). Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine. npj Vaccines. 7(1). 154–154. 7 indexed citations

Goh, Yun Shan, Siew‐Wai Fong, Pei Xiang Hor, et al.. (2022). Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections. Frontiers in Microbiology. 13. 1043049–1043049. 1 indexed citations

10.

Syenina, Ayesa, Esther S. Gan, Ruklanthi de Alwis, et al.. (2022). Adverse effects following anti–COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes. PLoS Biology. 20(5). e3001643–e3001643. 29 indexed citations

11.

Ku, Chee Wai, See Ling Loy, Karrie Kwan Ki Ko, et al.. (2021). Validation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19. International Journal of Infectious Diseases. 104. 255–261. 26 indexed citations

12.

Kalimuddin, Shirin, et al.. (2021). Acute acalculous cholecystitis in dengue fever: a case series. Singapore Medical Journal. 65(6). 364–367. 2 indexed citations

13.

Tan, Anthony T., Martin Linster, Chee Wah Tan, et al.. (2021). Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Reports. 34(6). 108728–108728. 440 indexed citations breakdown →

14.

Ong, Eugenia Z., Shirin Kalimuddin, Hwee Cheng Tan, et al.. (2021). Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution. EBioMedicine. 65. 103262–103262. 18 indexed citations

15.

Ong, Eugenia Z., Yvonne Fu Zi Chan, Shirin Kalimuddin, et al.. (2020). A Dynamic Immune Response Shapes COVID-19 Progression. Cell Host & Microbe. 27(6). 879–882.e2. 203 indexed citations

16.

Ho, Liam Pock, Shirin Kalimuddin, Benjamin Pei Zhi Cherng, et al.. (2020). Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition. 79-80. 111017–111017. 218 indexed citations

17.

Kalimuddin, Shirin, Satoru Watanabe, Kitti Wing Ki Chan, et al.. (2020). 18F-fluorodeoxyglucose positron emission tomography as a window into human dengue pathophysiology. Antiviral Research. 185. 104991–104991. 3 indexed citations

18.

Kalimuddin, Shirin, Rachel Phillips, Sophia Archuleta, et al.. (2018). A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study. Trials. 19(1). 305–305. 11 indexed citations

19.

Chacko, Ann‐Marie, Satoru Watanabe, Shirin Kalimuddin, et al.. (2017). 18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response. JCI Insight. 2(9). 29 indexed citations

20.

Molton, James S., Kelly L. Wyres, Claire L. Gorrie, et al.. (2016). Differential host susceptibility and bacterial virulence factors driving Klebsiella liver abscess in an ethnically diverse population. Scientific Reports. 6(1). 29316–29316. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact